That trust is held up by the daily judgments of every person working in pharma.
A learning notebook that supports those judgments, in one place.
Every task in pharma, in the end, comes down to one question: "Did we live up to the patient's trust?" A single act of bad faith can erase, in an instant, trust built up over many years. Trust is not something handed to you as a result. It is what each of us must protect, judgment by judgment, every single day. This site gathers the learning that supports those judgments.
The most important thing for preserving trust is the discipline of periodically questioning ourselves. We continuously publish current developments and historical lessons in a verified form, creating a "space for self-examination" that one can always return to. Only material that has passed verification is placed here, regardless of format or domain.
Pharma is a profession that takes on others' lives. By right, it should be one of the most respected industries in society — but the memory of drug-induced harm, conflicts of interest, and dishonest promotion has made it difficult for individuals to speak proudly about their work's significance. We aim to recover, from the ground up, an industry where each person can explain in their own words why their work matters.
"Not violating the rules" and "being ethical" are different things. When in doubt, we anchor not to the letter of the rule but to "the patient in front of you, and the version of yourself ten years from now." Ethics is not the memorization of answers — it is the attitude of continuing to ask.
The laws, self-regulatory codes, and guidelines that exist today are agreements forged in exchange for past drug disasters and incidents. Memorizing the text is not enough — only by reading the stories behind them do regulations become internalized. Read them not as "annoying rules" but as the testaments of those who came before.
Technology is merely a tool that gains meaning only when it reaches the patient. We prize asking well, choosing well, and stopping well over the pursuit of the latest. The starting point is "we use it because we should," not "we use it because we can."
Foundations of pharma / Regulation and field practice / Perspectives / AI series / Daily notes ── the full chapter map aligned with the top navigation.
Answers your questions on the spot, grounded only in materials stored on this site. It uses Anthropic's Sonnet, which can be wrong, so please verify against primary sources yourself before relying on any answer. A consent check appears on first use.
Open chat →From sulfanilamide to the opioid crisis. The classic cases that built regulation, Japan's drug disasters, and modern scandals ── 10 chapters.
View chapter →What ethics is. Nuremberg to Helsinki, the four principles of medical ethics, corporate and individual professional ethics ── 8 chapters.
View chapter →Conflict of interest, anti-bribery, internal control, data integrity, whistleblowing — both personal conduct and organizational design ── 6 chapters.
View chapter →PAA Articles 66-68 / Advertising Appropriateness Standards / MSA Guidelines and their Q&A / JPMA Code / the JPMA material-creation guide ── 7 chapters.
View chapter →The map · international lens · mindset · solitude · risk · perspective · per-medium practice · culture ── 8-part / 29-volume series.
View chapter →Quality assurance for client-commissioned materials. Regulatory conformance / AI review / QC·QA SOPs / four-signature delivery. NEW.
View chapter →The intermediate gate before vendor deliverables get forwarded into internal material review. A moral-responsibility framework. NEW.
View chapter →Material review depends on people. Two series × 10 parts: an 8-dimension competency framework and a qualification bar for independent review. Material Review 2.0 for the AI era. NEW.
View chapter →What material review means to the business, reread from the views of the capitalist, the board, the executives and risk management.
View chapter →Self-Understanding (Jung, Freud, Adler), Recognizing Overconfidence (Dunning-Kruger), and Self-Affirmation & Self-Criticism (modern psychology after Baumeister). Inner mirror practice: 3 × 10 = 30 articles.
View chapter →Self-Transformation (acceptance + change) and Confidence (self-efficacy, practical confidence). Changing the inner self: 2 × 10 = 20 articles.
View chapter →Correctness vs. reach, zero-risk illusion, delivering feedback, the choice of silence. Engaging with others: 10 articles, plus “The Justice Disease”, a three-part story about judging in black and white.
View chapter →Vol 1–5: what AI changed · terms and concepts · hands-on · 30 min of daily AI use · decks and diagrams.
View basics →AI Marketing (10-part series · Vol 01 available) · AI Programming · AI Medical ── three applied series.
View applied series →Industry AI dynamics, recorded with sources. Business · Tech · Medical · International · Essay ── 5-tab filter.
Read articles →Anthropic, OpenAI, Google, Meta, xAI, Microsoft, DeepSeek — AI regulation, new products, and notable figures, auto-aggregated twice daily (06:05 / 18:05 JST). Rolling 7-day daily archive.
Open chapter →A daily record of how much pharmaceutical companies put into AI, where and why — classified across 15 functions from drug discovery and clinical development to GQP, HR and finance. Amounts are extracted from source reporting only.
Open section →Fifteen minutes on today's AI, for the days you cannot read. One explainer a day, built only from this site's articles for that date. It works as audio alone when you cannot watch, and the full transcript and sources sit on the same page.
Watch →Advertising Regulation in Japan (Promotional Material Review) and Artificial Intelligence is an individually-run educational portal for those facing ethics, regulation, and technology in the pharmaceutical industry. Materials are added continuously across domains.
An independent editor with hands-on experience in pharma, building this site as a place where ethics, regulation, drug-disaster history, and AI are connected through a single question: how do we keep living up to the patient's trust?